Lv11
40 积分 2025-07-26 加入
Advances in the Pathogenesis and Treatment Strategies for Type 1 Diabetes Mellitus
9分钟前
已完结
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials
3天前
已完结
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma
15天前
已完结
Effect of Induction Therapy With Olamkicept vs Placebo on Clinical Response in Patients With Active Ulcerative Colitis
20天前
已完结
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study
22天前
已完结
The efficacy of longer-term lebrikizumab treatment in patients with moderate-to-severe atopic dermatitis who did not meet protocol-defined response criteria at week 16 in two randomized controlled clinical trials
23天前
已关闭
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials
25天前
已完结
Prevalence and Incidence of Prurigo Nodularis: A Systematic Review of Population-Based Studies
1个月前
已完结
Pathogenesis of Chronic Spontaneous Urticaria Beyond Autoantibodies
1个月前
已关闭
An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study
1个月前
已完结
皖公网安备34019202002308
